Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

The Romans created a remarkably organized and well-structured society. A big part of that was writing; they wrote often, and ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis.

Microsoft’s artificial intelligence group has been growing under Mustafa Suleyman, a co-founder of the DeepMind research lab ...

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

A University of Warwick epigraphy expert has collaborated with Google DeepMind to evaluate "Aeneas," an AI model that ...

Prescription drugs designed by AI could be in clinical trials within years, DeepMind's CEO predicted. Demis Hassabis said in an interview he'd be "disappointed" if it took more than a couple of years.

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. ... Murdoch says human clinical trials for Isomorphic’s AI-designed drugs are finally ...

DeepMind, the artificial intelligence company acquired by Alphabet in 2014, is merging with Google’s Brain team to form Google DeepMind. Google is combining the groups as it significantly ups ...

Google DeepMind unveiled GenCast, its AI tool for weather forecasts. GenCast outperformed existing forecasting systems in trials, Google DeepMind said. Better forecasting will allow for better ...